ArticleCells2022
Therapeutic Validation of GEF-H1 Using a De Novo Designed Inhibitor in Models of Retinal Disease.
Clare Mills et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
9 papers cite it
this papercites it
ArticleCells2022
Clare Mills et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.